NCT06167941View on ClinicalTrials.gov

Identification of Integrin ab Expression in Lung Cancer Patients

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

December 19, 2019

Primary Completion Date

September 10, 2021

Study Completion Date

November 25, 2021

Conditions
Expression of Integrin ανβ3 in Lung Cancer
Interventions
BIOLOGICAL

Lung cancer types

Cancer tissue matched to normal tissue, all from the same patient

Trial Locations (1)

08308

Department of Thoracic and Cardiovascular Surgery, Korea University Guro Hospital, Seoul

All Listed Sponsors
lead

Korea University Guro Hospital

OTHER

NCT06167941 - Identification of Integrin ab Expression in Lung Cancer Patients | Biotech Hunter | Biotech Hunter